Díaz-Rubio M - Search Results

1

CYP2A6 gene polymorphism and risk of liver cancer and cirrhosis.

Gullstén H, Agúndez JA, Benítez J, Läärä E, Ladero JM, Díaz-Rubio M, Fernandez-Salguero P, Gonzalez F, Rautio A, Pelkonen O, Raunio H. Gullstén H, et al. Pharmacogenetics. 1997 Jun;7(3):247-50. doi: 10.1097/00008571-199706000-00010. Pharmacogenetics. 1997. PMID: 9241665 No abstract available.

2

Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolizers.

Agúndez JA, Olivera M, Ladero JM, Rodriguez-Lescure A, Ledesma MC, Diaz-Rubio M, Meyer UA, Benítez J. Agúndez JA, et al. Pharmacogenetics. 1996 Dec;6(6):501-12. doi: 10.1097/00008571-199612000-00003. Pharmacogenetics. 1996. PMID: 9014199

3

Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding.

Blanco G, Martínez C, Ladero JM, Garcia-Martin E, Taxonera C, Gamito FG, Diaz-Rubio M, Agundez JA. Blanco G, et al. Pharmacogenet Genomics. 2008 Jan;18(1):37-43. doi: 10.1097/FPC.0b013e3282f305a9. Pharmacogenet Genomics. 2008. PMID: 18216720

4

N-acetyltransferase 2 polymorphism is not related to the risk of advanced alcoholic liver disease.

Agúndez JA, Ladero JM, Olivera M, Lozano L, Fernández-Arquero M, de laConcha EG, Díaz-Rubio M, Benitez J. Agúndez JA, et al. Scand J Gastroenterol. 2002 Jan;37(1):99-103. doi: 10.1080/003655202753387437. Scand J Gastroenterol. 2002. PMID: 11858170

5

Rsa I polymorphism at the cytochrome P4502E1 locus is not related to the risk of alcohol-related severe liver disease.

Agúndez J, Ladero J, Díaz-Rubio M, Benítez J. Agúndez J, et al. Liver. 1996 Dec;16(6):380-3. doi: 10.1111/j.1600-0676.1996.tb00766.x. Liver. 1996. PMID: 9021717

6

Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk.

Martínez C, García-Martín E, Ladero JM, Sastre J, Garcia-Gamito F, Diaz-Rubio M, Agúndez JA. Martínez C, et al. Carcinogenesis. 2001 Aug;22(8):1323-6. doi: 10.1093/carcin/22.8.1323. Carcinogenesis. 2001. PMID: 11470765

7

CYP2D6 genes and risk of liver cancer.

Agúndez JA, Ledesma MC, Benítez J, Ladero JM, Rodríguez-Lescure A, Díaz-Rubio E, Díaz-Rubio M. Agúndez JA, et al. Lancet. 1995 Apr 1;345(8953):830-1. doi: 10.1016/s0140-6736(95)92965-7. Lancet. 1995. PMID: 7898230

8

Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma.

Agúndez JA, García-Martín E, Devesa MJ, Carballo M, Martínez C, Lee-Brunner A, Fernández C, Díaz-Rubio M, Ladero JM. Agúndez JA, et al. Oncology. 2012;82(1):35-40. doi: 10.1159/000335606. Epub 2012 Jan 26. Oncology. 2012. PMID: 22286521

9

RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma.

Ladero JM, Agúndez JA, Rodríguez-Lescure A, Diaz-Rubio M, Benítez J. Ladero JM, et al. Gut. 1996 Aug;39(2):330-3. doi: 10.1136/gut.39.2.330. Gut. 1996. PMID: 8977352 Free PMC article.

10

Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use.

Martínez C, Blanco G, Ladero JM, García-Martín E, Taxonera C, Gamito FG, Diaz-Rubio M, Agúndez JA. Martínez C, et al. Br J Pharmacol. 2004 Jan;141(2):205-8. doi: 10.1038/sj.bjp.0705623. Epub 2004 Jan 5. Br J Pharmacol. 2004. PMID: 14707031 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters